Andrzej Tykarski

Długa 1/2 Street
Poznan, WP 61848, Poland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 196 publications

Selective dysfunction of e-series inflammation resolution in diabetes: the e-series resolution dysfunction index as a novel biomarker in chronic coronary syndrome.

Selective dysfunction of e-series inflammation resolution in diabetes: the e-series resolution dysfunction index as a novel biomarker in chronic coronary syndrome.

Journal: Polish archives of internal medicine

Published: July 07, 2026

Threonine in Coronary Artery Disease: Insights From Metabolic Syndrome Amino Acid Profiling.

Threonine in Coronary Artery Disease: Insights From Metabolic Syndrome Amino Acid Profiling.

Journal: Medical science monitor : international medical journal of experimental and clinical research

Published: June 24, 2026

Differential Regulation of Inflammatory and Pro-Resolving Lipid Mediators in Chronic Coronary Syndrome Across Cardiometabolic Phenotypes.

Differential Regulation of Inflammatory and Pro-Resolving Lipid Mediators in Chronic Coronary Syndrome Across Cardiometabolic Phenotypes.

Journal: International journal of molecular sciences

Published: June 02, 2026

The expert position of the Polish Cardiac Society, the Polish Society of Hypertension, and the Polish Society of Nephrology on renal denervation.

The expert position of the Polish Cardiac Society, the Polish Society of Hypertension, and the Polish Society of Nephrology on renal denervation.

Journal: Kardiologia polska

Published: April 22, 2026

Association between serum amino acid profiles and clinical severity in heart failure with reduced ejection fraction: an exploratory study.

Association between serum amino acid profiles and clinical severity in heart failure with reduced ejection fraction: an exploratory study.

Journal: Polish archives of internal medicine

Published: April 10, 2026

Amino Acid-Derived Metabolic Signature Across Stages of Systolic Dysfunction: Derivation and Internal Evaluation of the HASI (Heart Failure Amino Acid-Derived Systolic Index)-40 Index.

Amino Acid-Derived Metabolic Signature Across Stages of Systolic Dysfunction: Derivation and Internal Evaluation of the HASI (Heart Failure Amino Acid-Derived Systolic Index)-40 Index.

Journal: International journal of molecular sciences

Published: March 29, 2026

Hair Trace Element Imbalance in Smokers with HFpEF: A Pilot Study of Micronutrient and Metal Homeostasis.

Hair Trace Element Imbalance in Smokers with HFpEF: A Pilot Study of Micronutrient and Metal Homeostasis.

Journal: Biomedicines

Published: March 17, 2026

Average Real Variability Is an Independent Predictor of Increased Arterial Stiffness Assessed by Pulse Wave Velocity.

Average Real Variability Is an Independent Predictor of Increased Arterial Stiffness Assessed by Pulse Wave Velocity.

Journal: Journal of clinical hypertension (Greenwich, Conn.)

Published: March 08, 2026

Serum-to-hair Zn ratio as an index of zinc dyshomeostasis in HFpEF patients.

Serum-to-hair Zn ratio as an index of zinc dyshomeostasis in HFpEF patients.

Journal: Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements (GMS)

Published: February 27, 2026

Differences in Scalp Hair Trace Element Concentrations in Patients with Preserved Left Ventricular Ejection Fraction (HFpEF) Compared with Controls: A Hypothesis-Generating Study.

Differences in Scalp Hair Trace Element Concentrations in Patients with Preserved Left Ventricular Ejection Fraction (HFpEF) Compared with Controls: A Hypothesis-Generating Study.

Journal: Journal of clinical medicine

Published: January 27, 2026

Expert consensus for the diagnosis and treatment of patients with hyperuricemia and high cardiovascular risk: 2025 update.

Expert consensus for the diagnosis and treatment of patients with hyperuricemia and high cardiovascular risk: 2025 update.

Journal: European journal of internal medicine

Published: December 14, 2025

Nebivolol treatment improves hypertension-induced endothelial cell dysfunction by reducing TGF-β1-dependent senescence and normalizing mitochondrial indices.

Nebivolol treatment improves hypertension-induced endothelial cell dysfunction by reducing TGF-β1-dependent senescence and normalizing mitochondrial indices.

Journal: Journal of hypertension

Published: December 09, 2025

Showing 1-12 of 196

Last Updated: 09/26/2026